NEMO: A Novel Prognostic Model of Non-Icans Neurotoxicities Associated with Ciltacabtagene AutoleucelYein Jeon, Jordan Gauthier, Mazyar Shadman et al.|Transplantation and Cellular Therapy|2026Cited by 0
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or FludrocortisoneChristy Khouderchah, Mazyar Shadman, Mehdi Karami et al.|Transplantation and Cellular Therapy|2026Cited by 0
ALC Kinetics Velocity and Acceleration Are Early Predictors of Non-Icans Neurotoxicities after Cilta-Cel TreatmentYein Jeon, Jordan Gauthier, Xiancheng Wu et al.|Transplantation and Cellular Therapy|2026Cited by 0
CAR-T Access Barriers in Washington: Experience from a Single Primary Referral Center Prior to Implementing Program Capacity ExpansionMelinda A. Biernacki, Folashade Otegbeye, Dwight C Macero et al.|Transplantation and Cellular Therapy|2026Cited by 0